TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX)

CUSIP: 89854M101

Q1 2024 13F Holders as of 31 Mar 2024

Security identity
Shares outstanding
55,838,719
Holder snapshot
Share change
+2,378,550
Reported price per share
$7.94
Number of holders
65
Value change
+$19,079,789
Number of buys
38
Number of sells
14

Security key

89854M101

Report period

Q1 2024

Institutions

65

Top holders

10

Ownership snapshot

Top reported holders of TCRX - TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Lynx1 Capital Management LP
13D/G signal
Evidence rows
15
Latest as of
31 Dec 2023
13F 3/4/5 Lead comparable stake: 9.4% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Lynx1 Capital Management LP
13F
Company
13F
9.4%
$30,459,418
5,224,600 shares
31 Dec 2023
EcoR1 Capital, LLC
13F 3/4/5
Company · 10%+ Owner
9%
$29,150,000
5,000,000 shares
31 Dec 2023
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
7%
$22,737,000
3,900,000 shares
31 Dec 2023
BVF INC/IL
13F
Company
13F
5.4%
$17,428,633
2,989,474 shares
31 Dec 2023
BAKER BROS. ADVISORS LP
13F
Company
13F
5%
$16,235,337
2,784,792 shares
31 Dec 2023
Propel Bio Management, LLC
13F
Company
13F
3.7%
$12,168,020
2,087,139 shares
31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
65
Shares
34,291,369
Rows available
65
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
54
Q1 2024 holders
65
Holder diff
11
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .